130 related articles for article (PubMed ID: 33553848)
1. Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis.
Karimi S; Arabi A; Shahraki T
J Curr Ophthalmol; 2020; 32(4):420-422. PubMed ID: 33553848
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy.
Amaro MH; Roller AB
Arq Bras Oftalmol; 2012; 75(4):273-6. PubMed ID: 23258660
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of choroidal neovascularization complicating a choroidal osteoma with intravitreal bevacizumab.
Rao S; Gentile RC
Retin Cases Brief Rep; 2010; 4(4):303-5. PubMed ID: 25390904
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma.
Shields CL; Salazar PF; Demirci H; Benson WE; Shields JA
Retin Cases Brief Rep; 2008; 2(1):18-20. PubMed ID: 25389607
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab.
Cavalcante ML; Villegas VM; Gold AS; Cavalcante LL; Lonngi M; Shah NV; Murray TG
Clin Ophthalmol; 2014; 8():1377-82. PubMed ID: 25092961
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab for the treatment of a complicated posterior melanocytoma.
Urrets-Zavalia JA; Crim N; Esposito E; Correa L; Gonzalez-Castellanos ME; Martinez D
Clin Ophthalmol; 2015; 9():455-9. PubMed ID: 25834382
[TBL] [Abstract][Full Text] [Related]
8. Bilateral choroidal neovascularization associated with gyrate atrophy managed with intravitreal bevacizumab.
Inanc M; Tekin K; Teke MY
Int Ophthalmol; 2018 Jun; 38(3):1351-1355. PubMed ID: 28560651
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy.
Kapoor KG; Bakri SJ
J Ocul Pharmacol Ther; 2013 May; 29(4):444-7. PubMed ID: 23581613
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for iatrogenic choroidal neovascular membrane following vitreoretinal surgery for retinal detachment.
Appanraj R; Duraiswamy H; Saravanan V; Manayath G; Venkatapathy N
Indian J Ophthalmol; 2020 Jun; 68(6):1201-1203. PubMed ID: 32461482
[TBL] [Abstract][Full Text] [Related]
12. An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report.
Karampelas M; Soumplis V; Karagiannis D; Parikakis E; Webster AR
BMC Res Notes; 2013 Dec; 6():530. PubMed ID: 24325973
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2.
Gonzalez Martinez OG; Ayala RodrÃguez SC; Pappaterra-Rodriguez M; Requejo-Figueroa G; Oliver AL
Cureus; 2023 Jun; 15(6):e40528. PubMed ID: 37461786
[TBL] [Abstract][Full Text] [Related]
17. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
[TBL] [Abstract][Full Text] [Related]
18. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
Mennel S; Meyer CH; Callizo J
Acta Ophthalmol; 2010 Aug; 88(5):610-3. PubMed ID: 19222401
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.
Yoshikawa T; Takahashi K
Clin Ophthalmol; 2015; 9():429-37. PubMed ID: 25784788
[TBL] [Abstract][Full Text] [Related]
20. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
